Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Mar. 31, 2013

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

(In millions, except per share amounts)	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Fiscal 2013
Revenues	$	30,798	$	29,850	$	31,187	$	30,620
Gross profit	1,600		1,720		1,668		1,996
Net income (1) (2) (3) (4) (5)	380		401		298		259
Earnings per common share (1) (2) (3) (4) (5) (8)
Diluted	$	1.58	$	1.67	$	1.24	$	1.10
Basic	1.61		1.70		1.27		1.12
Fiscal 2012
Revenues	$	29,980	$	30,216	$	30,839	$	31,699
Gross profit	1,509		1,647		1,566		1,845
Net income (6) (7)	286		296		300		521
Earnings per common share (6) (7) (8)
Diluted	$	1.13	$	1.18	$	1.20	$	2.09
Basic	1.15		1.20		1.22		2.14

(1) Financial results for the first, second and fourth quarters of 2013 include AWP litigation charges of $16 million pre-tax ($10 million after-tax), $44 million pre-tax ($27 million after-tax) and $12 million pre-tax ($8 million after-tax), which were recorded in operating expenses.

(2) Financial results for the first quarter of 2013 include an $81 million pre-tax ($51 million after-tax) gain on business combination, which was recorded as a reduction to operating expenses.

(3) Financial results for the second, third and fourth quarters of 2013 include the pre-tax receipts of $19 million, $8 million and $17 million representing our share of settlements of antitrust class action lawsuits brought against drug manufacturers, which were recorded as a reduction to cost of sales.

(4) Financial results for the third quarter of 2013 include a $40 million pre-tax ($29 million after-tax) charge for a legal dispute in our Canadian business which was recorded in operating expenses.

(5) Financial results for the fourth quarter of 2013 include the following pre-tax impairment charges: an equity investment of $191 million, goodwill of $36 million, and capitalized software held for sale of $10 million.

(6) Financial results for the second, third and fourth quarters of 2012 include AWP litigation charges of $118 million pre-tax ($77 million after-tax), $27 million pre-tax ($15 million after-tax) and $4 million pre-tax (benefit of $32 million after-tax), which were recorded in operating expenses.

(7) Financial results for the third and fourth quarters of 2012 include product alignment pre-tax charges of $42 million and $9 million.

(8) Certain computations may reflect rounding adjustments.